Prevalence of lower extremity Peripheral artery disease among adult diabetes patients in Southwestern Uganda

Table 2 Unadjusted analysis of predictors of Peripheral Artery Disease

Characteristic	OR (95% CI)	p-value
Female sex	2.47 (1.22–5.01)	0.0001
Smoking history	1.04 (0.56–1.93)	0.894
Duration of diabetes > 5 years	3.38 (0.94–12.15)	0.062
Family history of diabetes	1.37 (0.73–2.56)	0.326
Presence of claudication symptoms	0.93 (0.51–1.71)	0.819
Self-reported hypertension^¥	1.96 (0.95–3.26)	0.072
Current elevated blood pressure^β	2.73 (1.42–5.25)	0.003
HIV infection	0.61 (0.17–2.19)	0.451
Metformin use	0.74 (0.39–1.42)	0.367
Glibenclamide use	3.16 (1.50–6.66)	0.002
Insulin use	1.24 (0.65–2.38)	0.517
Obesity, BMI ≥ 30 Kg/m²	1.23 (0.59–2.53)	0.576
Waist-to-hip ratio ≥ 0.81 (F) or ≥ 0.96 (M)	0.83 (0.21–3.26)	0.796
Cholesterol ≥ 190 mg/dL	0.9 (0.41–1.98)	0.794
HDL^€ ≤ 40 mg/dL	1.21 (0.61–2.41)	0.581
LDL^α ≥ 100 mg/dL	1.39 (0.69–2.78)	0.355
TG^∞ ≥ 200 mg/dL	0.75 (0.34–1.67)	0.483
FBS^μ < 3.9 or > 7.2 mmol/L	0.87 (0.46–1.65)	0.679
HbA1c^£ > 7.0% (53 mmol/mol)	0.75 (0.39 - 1.41)	0.368

Self-reported hypertension^¥: prior diagnosis of hypertension and taking antihypertensive drugs; Current elevated blood pressure^β: clinic systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg; OR: Odds ratio; BMI: body mass index; HDL^€: High-density Lipoprotein- cholesterol; LDL^α: Low-density lipoprotein-cholesterol; TG^∞: Triglycerides; FBS^μ: fasting blood sugar; HbA1c^£: glycated hemoglobin.

ISSN: 1471-2261